Trials / Completed
CompletedNCT06391931
A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 2 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, open, controlled, Phase III clinical study to evaluate the efficacy and safety of Cipepofol injection for general anesthesia in pediatric patients undergoing elective surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cipepofol | 0.6±0.2 mg/kg induce + 0.8 mg/kg/h maintain |
| DRUG | Propofol | 3.0 mg/kg induce + 5.0 mg/kg/h maintain |
Timeline
- Start date
- 2024-04-07
- Primary completion
- 2024-11-06
- Completion
- 2024-11-28
- First posted
- 2024-04-30
- Last updated
- 2025-07-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06391931. Inclusion in this directory is not an endorsement.